Good morning, everyone, and how are you today? The weekend may have gone by too quickly, but we hope you found it relaxing. Now, though, the time has come to resume that demanding routine of meetings and deadlines. We can relate and so we are brewing that mandatory cup of stimulation to cope. Our flavor today, by the way, is Pumpkin Spice. Please join us or grab a bottle of water, if you prefer. Meanwhile, here are some tidbits. And let us know if you hear something interesting. Good luck...
Valent Tops Paladin With New Afexa Offer (Reuters)
Pfizer Debt Ratings Cut By Fitch Over Wyeth Takeover Debt (Bloomberg News)
Roche Looks For $10B In Sales From HDL Cholesterol Pill (Reuters)
Glaxo Fails Again To Win FDA OK For Meningitis Vaccine (Bloomberg News)
Arrest Made In Nurofen Sabotage Case (The Telegraph)
Teva Buys Rest Of Japanese JV For $150M (Reuters)
Bayer Drug Hailed As Prostate Cancer Game Changer (The Street)
Fire Causes Damage At Orchid Chemical Facility (The Hindu)
Study Finds Novartis' Afinitor Improves Survival In Breast Cancer (Bloomberg News)
FDA OKs J&J's Remicade For Ulcerative Colitis In Kids (Pharma Times)
Closing Arguments In Motrin Trial Over Skin Disorder (Beverly Hills Courier)
Roche Hopes Boosted By Cancer Study Of 'Armed' Antibody (Reuters)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr